(UroToday.com) The 2024 SUO annual meeting included a session on non muscle invasive bladder cancer, featuring a presentation by Dr. Ashish Kamat discussing BCG unresponsive cancer in 2024.

Discover real-world data showing that only a minority of patients complete the recommended 4–6 chemotherapy cycles in bladder ...

Discover a study comparing two types of treatment for bladder cancer, robot-assisted radical cystectomy and intracorporeal ...

At ESMO 2024, Dr. Andrea Necchi presented the results of an interim analysis of SunRISe-4, noting a pathological complete response rate in the combination arm of 42% and pathologic objective response ...

Initial Keytruda showed consistent antitumor activity and safety in patients with advanced bladder cancer ineligible for ...

Breast, bladder, and pancreatic cancers are increasingly being treated with a broad range of therapies before a patient ...

Adjuvant Opdivo showed a significant improvement in overall survival and disease-free survival for patients with high-risk ...

Men who had radiotherapy to treat their prostate cancer were three times more likely to develop bladder cancer compared with ...

An independent neurosurgeon found that there was a failure to detect the bladder tumour when it was initially suspected ...

The TNM staging approach, which stands for tumour, nodes, and metastasis, is the most widely used method for staging prostate ...

Clinical factors associated with an increased risk of psychological distress included younger age, female sex, advanced pathological/tumor stage, and preoperative setting.